Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 28, 2015; 21(40): 11282-11303
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11282
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11282
Table 5 Risk factors associated to secondary failure or loss of response
Individual differences in bioavailability and pharmacokinetics |
Symptoms not due to inflammatory bowel disease |
Lack of adherence to therapy |
Drug loss in stools |
Intermittent treatments |
Non-inflammatory symptoms |
Structuring disease pattern |
Smoking |
Development of antibodies |
- Citation: Gómez-Gómez GJ, Masedo &, Yela C, Martínez-Montiel MDP, Casís B. Current stage in inflammatory bowel disease: What is next? World J Gastroenterol 2015; 21(40): 11282-11303
- URL: https://www.wjgnet.com/1007-9327/full/v21/i40/11282.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i40.11282